Search Results 4771-4780 of 33400 for oral

  1. Salivary gland tumors - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Oral Cavity Cancer and Reconstruction Clinic in Minnesota · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology ...

  2. Francis A. Farraye, M.D., M.S. - Mayo Clinic Faculty Profiles

    Other areas of active research include use of fecal calprotectin in patients with Crohn's disease after ileostomy and efficacy of oral contraceptives in ...

  3. Tongue cancer - Doctors and departments - Mayo Clinic

    Investigating tumor growth factors for oral cancer. Evaluating new methods of use for chemotherapy. Evaluating new radiation therapy regimens. Investigating ...

  4. Tongue cancer - Doctors and departments - Mayo Clinic

    Investigating tumor growth factors for oral cancer. Evaluating new methods of use for chemotherapy. Evaluating new radiation therapy regimens. Investigating the ...

  5. Exploratory Ph 2A, Double-Blind, Placebo-Controlled Dose Escalation Study of Safety, Tolerability, PD, & PK of HU6 for Subjects With Obese HFpEF - Mayo Clinic

    (Subjects may receive medication (for example, oral benzodiazepine) for ... Oral, intranasal or inhaled products with cannabidiol; d. Prescription or ...

  6. Publications - Michael S. Rutenberg, M.D., Ph.D. - Mayo Clinic

    Oral Maxillofac Surg Clin North Am. 2023 Aug; 35 (3):485-492 Epub 2023 Apr 26. View PubMed; Rutenberg MS, Hoppe BS, Starr JS, Awad Z, Thomas M, Morris CG ...

  7. Congenital Metabolic Disorder Clinical Trials - Mayo Clinic Research

    The purpose of this study is to assess the safety and tolerability of oral monosaccharide (galactose and fucose) treatment in a small pilot group of congenital ...

  8. Salivary gland tumors - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Oral Cavity Cancer and Reconstruction Clinic in Minnesota · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology ...

  9. A Study Comparing the Safety and Effectiveness of Lonapegsomatropin with Placebo and Somatropin in Adults with Growth Hormone Deficiency - Mayo Clinic

    ... oral glucose tolerance test) diagnosed <26 weeks prior to screening 3. Change in diabetes regimen (includes dose adjustment) within <90 days prior and

  10. Clinical trials - Oncology (Medical)

    ... oral chemotherapy regimens. Finally, this study will be the first to track the outcomes of subjects with disseminated B-cell Lymphoblastic Leukemia (B LLy) ...